TY - JOUR
T1 - Tuberculosis in drug users
AU - Perlman, David C.
AU - Salomon, Nadim
AU - Perkins, Mary Patricia
AU - Yancovitz, Stanley
AU - Paone, Denise
AU - Des Jarlais, Don C.
N1 - Funding Information:
Received 15 February 1995; revised 12 May 1995. This work was supported in part by the National Institute on Drug Abuse (R01-DA09005-01A1). Reprints or correspondence: Dr. David C. Perlman, Beth Israel Medical Center, First Avenue at 16th Street, New York, New York 10003.
PY - 1995/11
Y1 - 1995/11
N2 - The rise in tuberculosis (TB) has disproportionately affected specific populations. Historically, many patients with TB became iatrogenic opiate addicts through therapeutic use of these drugs for symptom control. Demographic trends reshaped the relationship between drug use and TB into one in which drug use became a risk factor for tuberculosis as a result of the overlap of epidemiological and social factors associated with both drug use and TB. The spread of human immunodeficiency virus infection has amplified the spread of TB among drug users. We review the epidemiology of TB in drug users as well as the factors relevant to screening and compliance in drug-using populations. Drug users constitute a high-risk group for whom screening, prevention of infection, diagnosis, and treatment pose particular challenges. The development of TB services capable of engaging drug users (those both in and out of drug treatment programs) has potential for disrupting a significant chain of rapid TB transmission.
AB - The rise in tuberculosis (TB) has disproportionately affected specific populations. Historically, many patients with TB became iatrogenic opiate addicts through therapeutic use of these drugs for symptom control. Demographic trends reshaped the relationship between drug use and TB into one in which drug use became a risk factor for tuberculosis as a result of the overlap of epidemiological and social factors associated with both drug use and TB. The spread of human immunodeficiency virus infection has amplified the spread of TB among drug users. We review the epidemiology of TB in drug users as well as the factors relevant to screening and compliance in drug-using populations. Drug users constitute a high-risk group for whom screening, prevention of infection, diagnosis, and treatment pose particular challenges. The development of TB services capable of engaging drug users (those both in and out of drug treatment programs) has potential for disrupting a significant chain of rapid TB transmission.
UR - http://www.scopus.com/inward/record.url?scp=85047696788&partnerID=8YFLogxK
U2 - 10.1093/clinids/21.5.1253
DO - 10.1093/clinids/21.5.1253
M3 - Article
C2 - 8589151
AN - SCOPUS:85047696788
VL - 21
SP - 1253
EP - 1264
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
SN - 1058-4838
IS - 5
ER -